openPR Logo
Press release

Anaphylaxis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Aquestive Therapeutics, Stella Pharma, Nasus Pharma, Shenox Pharmaceuticals, MannKind

11-01-2023 07:27 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Anaphylaxis Pipeline Analysis (2023) Covering Clinical

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 8+ pipeline drugs in the Anaphylaxis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Anaphylaxis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Anaphylaxis Therapeutics Market.

The report provides a detailed description of the Anaphylaxis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Anaphylaxis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/anaphylaxis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Anaphylaxis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Anaphylaxis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Anaphylaxis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Anaphylaxis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Anaphylaxis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Anaphylaxis Therapeutics Domain @
https://www.delveinsight.com/report-store/anaphylaxis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Anaphylaxis Therapeutics Analysis
There are approx. 8+ key companies developing therapies for Anaphylaxis. Currently, Hikma Pharmaceuticals is leading the therapeutics market with its Anaphylaxis drug candidates in the most advanced stage of clinical development.

Anaphylaxis Companies in the Therapeutics Market Include:
• Aquestive Therapeutics
• Stella Pharma
• Nasus Pharma
• Shenox Pharmaceuticals
• Hikma Pharmaceuticals
• MannKind
And Many Others

Emerging and Marketed Anaphylaxis Therapies Covered in the Report Include:
• AQST-108: Aquestive Therapeutics
• NS-002: Nasus Pharma
And Many More

Get an in-depth Assessment of the Emerging Therapies and Anaphylaxis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/anaphylaxis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Anaphylaxis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Anaphylaxis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Anaphylaxis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/anaphylaxis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Anaphylaxis Current Treatment Patterns
4. Anaphylaxis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Anaphylaxis Late-Stage Products (Phase-III)
7. Anaphylaxis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Anaphylaxis Discontinued Products
13. Anaphylaxis Product Profiles
14. Anaphylaxis Companies
15. Anaphylaxis Drugs
16. Dormant and Discontinued Products
17. Anaphylaxis Unmet Needs
18. Anaphylaxis Future Perspectives
19. Anaphylaxis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/anaphylaxis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Pulmonology Devices Market
https://www.delveinsight.com/report-store/pulmonology-devices-market

Small Cell Lung Cancer Market
https://www.delveinsight.com/report-store/small-cell-lung-cancer-market

Bronchiectasis Market
https://www.delveinsight.com/report-store/bronchiectasis-market

Lennox Gastaut Syndrome Market
https://www.delveinsight.com/report-store/lennox-gastaut-syndrome-market

Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market

Muscle Invasive Bladder cancer Market
https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market

Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

Anesthesia Machines Market
https://www.delveinsight.com/report-store/anesthesia-workstation-machines-market

Secondary Myelofibrosis Market
https://www.delveinsight.com/report-store/secondary-myelofibrosis-market

Guillain-Barre Syndrome (GBS) Market
https://www.delveinsight.com/report-store/guillain-barre-syndrome-gbs-market

Hepatitis A Market
https://www.delveinsight.com/report-store/hepatitis-a-market

Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-market

Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Factor XA Inhibitor Market
https://www.delveinsight.com/report-store/factor-xa-inhibitor-market

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market

Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market

Primary Progressive Multiple Sclerosis (PPMS) Market
https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market

Thalassemia Market
https://www.delveinsight.com/report-store/thalassemia-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anaphylaxis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Aquestive Therapeutics, Stella Pharma, Nasus Pharma, Shenox Pharmaceuticals, MannKind here

News-ID: 3272997 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Anaphylaxis

Anaphylaxis Treatment Market Report 2024 - Anaphylaxis Treatment Market Analysis …
"The Business Research Company recently released a comprehensive report on the Global Anaphylaxis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Anaphylaxis Treatment Market Insights, Forecast to 2031
"Anaphylaxis Treatment Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Anaphylaxis Treatment market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Anaphylaxis Treatment industry, providing stakeholders with a nuanced perspective on
Anaphylaxis Treatment Market Trends, Size, Forecast 2024-2033
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Anaphylaxis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $7.97 billion In 2028 At
Anaphylaxis Treatment Size Share and Forecast 2023
The global anaphylaxis treatment size was valued at USD 3,104.4 million in 2022 and is poised to grow at a significant CAGR of 8.9% during the forecast period 2023-29. The primary drivers of the expansion of the global anaphylaxis treatment market include the increasing incidence of allergies and anaphylaxis. In addition, increasing number of geriatric patients and increasing research and development activities is expected to boost the growth of anaphylaxis
Anaphylaxis Treatment Market Business Opportunities Forecast To 2028
The research report "Anaphylaxis Treatment Market: By Drug Class (Adrenergic Agents (Epinephrine), Anti-Histamines, Others), By Route of Administration (Parenteral, Oral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography." The global anaphylaxis treatment market was valued at USD 4,878.89 million in 2021 and is anticipated to grow at a CAGR of 8.9% during the forecast period 2022-2028. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-anaphylaxis-treatment-market/
Anaphylaxis Treatment Market Segments And Key Trends 2018 to 2028(Anaphylaxis Tr …
The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on